Deleterious effects of lack of compliance to lifestyle and medication in diabetic patients;Effets néfastes du défaut d'observance hygiéno- diététique et médicamenteuse chez le patient diabétique

Revue Medicale de Liege

Volumn 65, Issue 5-6, 2010, Pages 326-331

  Paquot, N ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Compliance; Diabetes; Diet; Medication

Indexed keywords

HEMOGLOBIN A1C; INSULIN; METFORMIN; PLACEBO;

COST OF ILLNESS; DRUG EFFECT; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; REVIEW; TREATMENT OUTCOME;

DIABETES MELLITUS; HUMANS; LIFE STYLE; PATIENT COMPLIANCE;

EID: 77954117081     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. DCCT Research Group. - The effect of intensive treatment of diabetes on the development and progression of long-trem complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993, 329, 977-986.
2. UK Prospective Diabetes Study Group. - Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment in patients with type 2 diabetes (UKPDS33). Lancet, 1998, 352, 837-853.
3. Field AE, Coakley EH, Must A, et al. - Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med, 2001, 161, 1581-1586. (Pubitemid 32681139)
4. Paquot N. - Le régime alimentaire chez le patient diabétique de type 2. Rev Med Liège, 2005, 60, 392-394.
5. Williams KV, Kelley DE. - Metabolic consequences of weight loss on glucose metabolism and insulin action in type 2 diabetes. Diabetes Obes Metab, 2000, 2, 121-129.
6. Diabetes Prevention Programm Research Group, Knowler WC, et al. - 10 years follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet, 2009, 374, 1677-1684.
7. Foreyt JP, Poston WS 2nd. - The challenge of diet, exercise and lifestyle modification in the management of the obese diabetic patient. Int J Obes Relat Metab Disord, 1999, 23 (Suppl 7), S5-11.
8. Scheen AJ, De Flines J, De Roover A, Paquot N. - Bariatric surgery in patients with type 2 diabetes : benefits, risks, indications and perspectives. Diabetes Metab, 2009, 35, 537-543.
9. Scheen AJ, Radermecker RP, Philips JC, et al. - Le traitement du diabète de type 2 : entre insulinosensibilisateurs et insulinosécrétagogues. Rev Med Liège, 2007, 62, 40-46.
10. Scheen AJ, Bruwier G, Schmitt H. - Optimalisation de la prise en charge du patient diabétique de type 2 : résultats de l'étude «DREAM» en médecine générale. Rev Med Liège, 2003, 58, 139-144.
11. Sauvanet JP. - Diabète : «observance ou alliance thérapeutique ». Diabetes Metab, 2005, 31, 214-216.
12. Pladevall M, Divine G, Williams LK, et al. - Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care, 2004, 27, 2800-2805.
13. Ho PM, Rumsfeld JS, Masoudi FA, et al. - Effect of medication nonadherence on hospitalizations and mortality among patients with diabetes mellitus. Arch Intern Med, 2006, 166, 1836-1841.
14. Morris AD, Boyle DIR, McMahon AD, et al. - Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. Lancet, 1997, 350, 1505-1510.
15. Ziegler O. - Prescrire une modification du comportement alimentaire. Rev Praticien, 2009, 59, 48-53.
16. Odegard PS, Capoccia K. - Medication taking and diabetes. A systematic review of literature. Diabetes Educ, 2007, 33, 1014-1029.
17. Mosnier-Pudar H. - Education thérapeutique du patient et diabète de type 2 : que nous apprend la littérature ? Médecine des maladies Métaboliques, 2007, 1, 80-87.
18. Farmer A, Kinmonth AL, Sutton S. - Measuring beliefs about taking hypoglycemic medication among people with type 2 diabetes. Diabet Med, 2006, 23, 265-270.
19. Grant RW, Devita ND, Singer DE, Meigs JB. - Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care, 2003, 26, 1408-1412.
20. Walker EA, Moltich M, Kramer MK, et al. - for the Diabetes Prevention Program Research Group. Adherence to preventive medications : predictors and outcomes in the prevention program. Diabetes Care, 2006, 29, 1997-2002.
21. Reach G. - Patient non-adherence and health-provider inertia are clinical myopia. Diabetes Metab, 2008, 34, 382-385.
22. Gerber RA, Cappelleri JC, Koudires IA, Gelfand RA. - Treatment satisfaction with inhaled insulin in patient with type 1 diabetes : a randomized controlled trial. Diabetes Care, 2001, 24, 1556-1559.
23. Vermeire E, Wens J, Van Royen P, et al. - Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. Cochrane Database Syst Rev, 2005, 2, CD003638.
24. 2. - L'éducation thérapeutique : une solution pour vaincre l'inertie clinique et le défaut d'observance. Rev Med Liège, 2010, 65, 250-255.
25. Melko CN, Terry PE, Camp K, Xi M, Healey ML. - Diabetes Health coaching improves medication adherence : a pilot study. Am J Lifestyle Med, 2010, 4, 1887-194.